Duoe Gog 3041 Engot En10 Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Duoe gog 3041 engot en10 trial . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Duoe Gog 3041 Engot En10 Trial Today - Breaking & Trending Today

Maintenance Durvalumab Plus Olaparib Improves PFS in Advanced or Recurrent Endometrial Cancer

The addition of durvalumab to first-line chemotherapy, followed by maintenance treatment with durvalumab plus olaparib significantly improved progression-free survival in patients with newly diagnosed advanced or recurrent endometrial cancer, according to data from the phase 3 DUO-E/GOG-3041/ENGOT-EN10 trial. ....

United States , P Ann Onc , Shannonn Westin , Department Of Gynecologic Oncology , University Of Texas Md Anderson Cancer Center , Division Of Surgery , Gynecologic Oncology , Reproductive Medicine , Cancer Center , Published October , Endometrial Cancer , Duo E , Duoe Gog 3041 Engot En10 Trial , Esmo Congress , The University Of Texas Md Anderson Cancer Center ,